Table 2.

Drug class for patients with A1c measurements

	All with A1c data	A1c ≥8%		A1c ≥9%
	n	n	%*	n	%*
Total	414 266	103 447	25.0	55 454	13.4
No drugs	51 505	875	1.7	287	0.6
OAD only	225 156	36 943	16.4	16 746	7.4
1 OAD	120 784	9 273	7.7	3 743	3.1
2 OADs	74 329	17 379	23.4	8 176	11.0
3+OADs	30 043	10 291	34.3	4 827	16.1
Insulin, w/wo OAD	112 111	55 668	49.7	32 998	29.4
GLP-1 RA, w/wo OAD	12 477	3 397	27.2	1 602	12.8
Insulin+GLP-1 RA, w/wo OAD	13 017	6 564	50.4	3 821	29.4

Category of A1c ≥8% reflects all patients at or over this cut-off (including ≥9%).

*% values reflect % across rows, with 'All with A1c data' column as the denominator.

GLP-1 RA, glucagon-like peptide 1 receptor agonist; OAD, oral antidiabetes drug; w/wo, with or without.